R&D SMEs at risk due to tax credit scheme change
The aim is to prevent fraud, but analysis by the BIA shows the measure will have unintended consequences for life science companies.
Read More
Tag: The BioIndustry Association
- NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats
- UCB reports superiority of bimekizumab in psoriatic arthritis study
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
